| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.2 |